Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Maravai LifeSciences Holdings, Inc. (MRVI) had Normalized Pre-Tax Income of $617.74M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$288.94M |
|
$-119.03M |
|
$148.74M |
|
$140.20M |
|
$320.59M |
|
$-31.65M |
|
$649.38M |
|
$617.74M |
|
|
Normalized Pre-Tax Income |
$617.74M |
$-138.38M |
|
$-138.38M |
|
$-138.38M |
|
$-138.38M |
|
$-31.65M |
|
$20.06M |
|
131.92M |
|
131.92M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$699.91M |
|
$162.90M |
|
$787.54M |
|
$1.49B |
|
$87.47M |
|
$550.60M |
|
$610.10M |
|
$697.57M |
|
$789.88M |
|
$242.87M |
|
$789.88M |
|
251.32M |
|
| Cash Flow Statement Financials | |
$126.22M |
|
$-122.31M |
|
$-61.09M |
|
$632.14M |
|
$574.96M |
|
$-57.18M |
|
$34.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.00 |
|
-- |
|
-- |
|
0.41 |
|
0.70 |
|
48.52% |
|
-10.95% |
|
-10.95% |
|
6.94% |
|
213.79% |
|
-41.19% |
|
$60.67M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
2.89 |
|
5.19 |
|
70.39 |
|
-17.52% |
|
-56.98% |
|
-9.30% |
|
-10.32% |
|
$3.14 |
|
$0.46 |
|
$0.96 |
|